By defining the molecular mechanisms linking lipid metabolism and inflammation resolution with FPR1 in gastrointestinal (GI) tract, our data will allow the comprehension of the general mechanisms involved in tumour cell growth following their angiogenic switch and will open the possibility to identify new prognostic markers and a novel therapeutic approach for cancers of the GI tract. This evidence concerns the gene FPR1 and cancer.